Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Protocatechuic Acid
2. Protocatechuic Acid, Carboxy-14c-labeled
3. Protocatechuic Acid, Monosodium Salt
1. Protocatechuic Acid
2. 99-50-3
3. 4-carboxy-1,2-dihydroxybenzene
4. Protocatehuic Acid
5. Protocatechuate
6. Benzoic Acid, 3,4-dihydroxy-
7. 4,5-dihydroxybenzoic Acid
8. Mfcd00002509
9. Catechol-4-carboxylic Acid
10. Ccris 6291
11. 3, 4-dihydroxybenzoic Acid
12. Chembl37537
13. Mls000737807
14. 36r5qj8l4b
15. Einecs 202-760-0
16. Chebi:36062
17. Nsc 16631
18. Brn 1448841
19. Nsc-16631
20. 1ykp
21. Protocatechuic Acid Polymer
22. 3,4-dihydroxy Benzoic Acid
23. Nsc16631
24. Db03946
25. Smr000528167
26. Unii-36r5qj8l4b
27. C00230
28. D-3487
29. Hypogallic Acid
30. B-resorcylate
31. Beta-resorcylate
32. Protocatechuicacid
33. B-resorcylic Acid
34. 4fht
35. Protacatechuic Acid
36. Zincselenite
37. Carbohydroquinonic Acid
38. Cid_72
39. Protocatechuic Acid,(s)
40. Protocatechoic Acid
41. Dsstox_cid_1212
42. Protocatechuic Acid (m1)
43. Bmse000328
44. 3,4-dihydroxy-benzoic Acid
45. Dsstox_rid_76012
46. Dsstox_gsid_21212
47. Schembl39435
48. 3,4-dihydroxybenzoate, Viii
49. Pyrocatechol-4-carboxylic Acid
50. Dtxsid4021212
51. Fema No. 4430
52. Protocatechuic Acid [mi]
53. Zinc13246
54. Protocatechuic Acid (pca)
55. Hms2270a17
56. Kuc104409n
57. Act07872
58. Hy-n0294
59. Tox21_200167
60. Bbl012232
61. Bdbm50100861
62. Dihydroxybenzoic Acid, 3,4-
63. S3975
64. Stl163570
65. Akos000119632
66. Ac-9617
67. Ccg-207950
68. Cs-6092
69. Ksc-10-128
70. Cas-99-50-3
71. Oxidative Polymer Of Protocatechuic Acid
72. Ncgc00246757-01
73. Ncgc00246757-02
74. Ncgc00257721-01
75. 3,4-dihydroxybenzoic Acid [inci]
76. As-10808
77. Sy014104
78. Db-021903
79. Am20060767
80. Ft-0600028
81. N2466
82. 3,4-dihydroxybenzoic Acid, >=97.0% (t)
83. 3,4-dihydroxybenzoic Acid, Analytical Standard
84. F11285
85. 3,4-dihydroxybenzoate;3,4-dihydroxybenzoic Acid
86. 002d509
87. A846038
88. Ae-562/40524392
89. Droxidopa Metabolite (protocatechoic Acid)
90. Q418599
91. 976c8cce-b25d-4e0a-9a6f-3ceea7a6964f
92. 3,4-dihydroxybenzoic Acid, Vetec(tm) Reagent Grade, 97%
93. Protocatechuic Acid, Primary Pharmaceutical Reference Standard
94. Protocatechoic Acid (constituent Of Maritime Pine) [dsc]
95. Protocatechuic Acid, United States Pharmacopeia (usp) Reference Standard
96. 1225528-47-1
| Molecular Weight | 154.12 g/mol |
|---|---|
| Molecular Formula | C7H6O4 |
| XLogP3 | 1.1 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 1 |
| Exact Mass | 154.02660867 g/mol |
| Monoisotopic Mass | 154.02660867 g/mol |
| Topological Polar Surface Area | 77.8 Ų |
| Heavy Atom Count | 11 |
| Formal Charge | 0 |
| Complexity | 157 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anticarcinogenic Agents
Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. (See all compounds classified as Anticarcinogenic Agents.)
Protocatehuic acid is a known human metabolite of 3,4-dihydroxyphenylacetic acid.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
15
PharmaCompass offers a list of 3,4-Dihydroxybenzoic Acid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right 3,4-Dihydroxybenzoic Acid manufacturer or 3,4-Dihydroxybenzoic Acid supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred 3,4-Dihydroxybenzoic Acid manufacturer or 3,4-Dihydroxybenzoic Acid supplier.
PharmaCompass also assists you with knowing the 3,4-Dihydroxybenzoic Acid API Price utilized in the formulation of products. 3,4-Dihydroxybenzoic Acid API Price is not always fixed or binding as the 3,4-Dihydroxybenzoic Acid Price is obtained through a variety of data sources. The 3,4-Dihydroxybenzoic Acid Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 3,4-Dihydroxybenzoic Acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 3,4-Dihydroxybenzoic Acid, including repackagers and relabelers. The FDA regulates 3,4-Dihydroxybenzoic Acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 3,4-Dihydroxybenzoic Acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 3,4-Dihydroxybenzoic Acid supplier is an individual or a company that provides 3,4-Dihydroxybenzoic Acid active pharmaceutical ingredient (API) or 3,4-Dihydroxybenzoic Acid finished formulations upon request. The 3,4-Dihydroxybenzoic Acid suppliers may include 3,4-Dihydroxybenzoic Acid API manufacturers, exporters, distributors and traders.
3,4-Dihydroxybenzoic Acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 3,4-Dihydroxybenzoic Acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 3,4-Dihydroxybenzoic Acid GMP manufacturer or 3,4-Dihydroxybenzoic Acid GMP API supplier for your needs.
A 3,4-Dihydroxybenzoic Acid CoA (Certificate of Analysis) is a formal document that attests to 3,4-Dihydroxybenzoic Acid's compliance with 3,4-Dihydroxybenzoic Acid specifications and serves as a tool for batch-level quality control.
3,4-Dihydroxybenzoic Acid CoA mostly includes findings from lab analyses of a specific batch. For each 3,4-Dihydroxybenzoic Acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
3,4-Dihydroxybenzoic Acid may be tested according to a variety of international standards, such as European Pharmacopoeia (3,4-Dihydroxybenzoic Acid EP), 3,4-Dihydroxybenzoic Acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (3,4-Dihydroxybenzoic Acid USP).
